Renal function and systolic blood pressure in very-low-birth-weight infants 1-3 years of age

Pediatr Nephrol. 2012 Dec;27(12):2285-91. doi: 10.1007/s00467-012-2265-y. Epub 2012 Jul 26.

Abstract

Background: Preterm very-low-birth-weight (PT-VLBW) infants are at risk of an elevated systolic blood pressure (SBP) in infancy and adulthood; however, the pathogenesis remains unclear. Altered renal development or function may be associated with increased SBP, but their contribution in PT-VLBW is unknown.

Methods: We determined renal function and its relationship to SBP in three groups of PT-VLBW at 1, 2, and 3 years of age, using serum cystatin-C to calculate the estimated glomerular filtration rate (eGFR).

Results: Cystatin-C levels decreased from 0.84 ± 0.2 (SD) within the 1-year group to 0.70 ± 0.1 mg/l (±SD; P < 0.001) at 3 years and were unrelated to gender, fetal growth, and neonatal indomethacin exposure. eGFR rose from 121 ± 59 in the 1-year group to 138 ± 21 ml/min · 1.73 m(2) (P < 0.001) at 3 years. At 1 year, cystatin-C levels decreased with increasing SBP (P < 0.007), and infants with SBP ≥ 90 th% had lower cystatin-C and higher eGFR (P < 0.05). At 3 years, infants with lower birth weight (P < 0.03) and gestational age (P = 0.06) had reduced eGFR.

Conclusions: Preterm very-low-birth-weight infants demonstrate increasing renal function with advancing age. An elevated SBP and eGFR at 1 year suggests dysfunctional renal autoregulation and hyperfiltration, which may alter subsequent renal function and contribute to the lower eGFR seen at 3 years in infants with the lowest birth weight and gestational age.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Pressure / physiology*
  • Child, Preschool
  • Cystatin C / analysis
  • Cystatin C / blood
  • Female
  • Glomerular Filtration Rate / physiology*
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature, Diseases*
  • Infant, Very Low Birth Weight / physiology*
  • Kidney / physiopathology*
  • Male

Substances

  • Cystatin C